Science Explorer Back to mapMap
Discussion
Company · Woburn · United States

CreaGen (United States)

creageninc.comROR OpenAlex
Research works
5
▼ 100% vs 2018-21
Citations
82
15.1 per fractional work
Top-10% rate
2.9%
all institutions 10.0%
Open access
54%
world 40%
International
23%
world 18%
CreaGen (United States)

Not ranked overall: CreaGen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CreaGen (United States) work in?

In all years, 52% of research at CreaGen (United States) is in Physical Sciences, 28% in Life Sciences. Its largest fields are Chemistry (46%), Medicine (19%), Biochemistry, Genetics and Molecular Biology (17%).

Physical Sciences: 3 fractional works · 52.5% of its workChemistry: 3 fractional works · 46.4% of its workOrganic Chemistry: 2 fractional works · 39.0% of its workInorganic Chemistry: 0 fractional works · 7.4% of its workMaterials Science: 0 fractional works · 6.1% of its workBiomaterials: 0 fractional works · 6.1% of its workLife Sciences: 2 fractional works · 28.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 17.1% of its workMolecular Biology: 1 fractional works · 9.8% of its workCancer Research: 0 fractional works · 6.1% of its workBiotechnology: 0 fractional works · 1.3% of its workImmunology and Microbiology: 0 fractional works · 7.4% of its workImmunology: 0 fractional works · 6.3% of its workMicrobiology: 0 fractional works · 1.3% of its workAgricultural and Biological Sciences: 0 fractional works · 3.7% of its workAgronomy and Crop Science: 0 fractional works · 1.3% of its workForestry: 0 fractional works · 1.3% of its workSoil Science: 0 fractional works · 1.3% of its workHealth Sciences: 1 fractional works · 19.3% of its workMedicine: 1 fractional works · 19.3% of its workGenetics: 0 fractional works · 6.1% of its workPharmacology: 0 fractional works · 5.2% of its workOncology: 0 fractional works · 5.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.3% of its workHepatology: 0 fractional works · 1.1% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workALL ITS WORKCreaGen (UnitedStates)5fractional works, all years
Life Sciences28%Physical Sciences52%Health Sciences19%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Chemistry346.4%
    2. Materials Science06.1%
    1. Biochemistry, Genetics and Molecular Biology117.1%
    2. Immunology and Microbiology07.4%
    3. Agricultural and Biological Sciences03.7%
    1. Medicine119.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from CreaGen (United States)?

    The most cited paper from CreaGen (United States) is "A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma" (Jeong‐Hoon Lee, Yoon Lee, Minjong Lee et al., 2015), with 110 citations. Next come "Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors" (48) and "Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy" (39).

    Most cited papers
    #PaperReleasedCitations
    1 A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Jeong‐Hoon Lee, Yoon Lee, Minjong Lee et al. · British Journal of Cancer Open access Dec 2015 110
    2 Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors Nam-Chul Jung, Hee Jung Kim, Mi-Sun Kang et al. · Cancer Letters 30 Apr 2012 48
    3 Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy Md. Selim Ahmed, Se Eun Byeon, Yideul Jeong et al. · OncoImmunology Open access 2 Jan 2015 39
    4 Actions of the Small Molecule Ligands SW106 and AH-3960 on the Type-1 Parathyroid Hormone Receptor Percy H. Carter, Thomas Roy Dean, Brijesh Bhayana et al. · Molecular Endocrinology Open access 13 Jan 2015 35
    5 Proteomic Analysis of the Hydrophobic Fraction of Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood Ju Ah Jeong, Yoon Min Lee, Woobok Lee et al. · Molecules and Cells Open access Aug 2006 19
    All 13 most cited papers, with filters and sorting

    Which research topics does CreaGen (United States) publish most on?

    By volume: Synthetic Organic Chemistry Methods, Catalytic Cross-Coupling Reactions, Cancer, Hypoxia, and Metabolism and Zeolite Catalysis and Synthesis.

    Synthetic Organic Chemis…1Synthetic Organic Chemistry Methods: 1 fractional worksCatalytic Cross-Coupling…0Catalytic Cross-Coupling Reactions: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksZeolite Catalysis and Synthesis: 0 fractional worksMesenchymal stem cell re…0Mesenchymal stem cell research: 0 fractional worksElectrospun Nanofibers in Biomedical Applications: 0 fractional worksInorganic and Organometallic Chemistry: 0 fractional worksSynthesis of Organic Com…0Synthesis of Organic Compounds: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksChemical synthesis and alkaloids: 0 fractional works
    Organic ChemistryCancer ResearchInorganic ChemistryGenetics3 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Synthetic Organic Chemistry Methods Organic Chemistry 1 works
    2. 2 Catalytic Cross-Coupling Reactions Organic Chemistry 0 works
    3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
    4. 4 Zeolite Catalysis and Synthesis Inorganic Chemistry 0 works
    5. 5 Mesenchymal stem cell research Genetics 0 works
    6. 6 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
    7. 7 Inorganic and Organometallic Chemistry Organic Chemistry 0 works
    8. 8 Synthesis of Organic Compounds Pharmacology 0 works
    9. 9 Immunotherapy and Immune Responses Immunology 0 works
    10. 10 Chemical synthesis and alkaloids Organic Chemistry 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available54.2%not open45.8%

    World: 40% of research is openly available.

    with international co-authors23.3%domestic only76.7%

    World: 18% is written across borders.

    How has CreaGen (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    20102015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is CreaGen (United States) as a percentage of every work published that year, 0.000018% in 2015.

    0.000020%0.000040%0.000060%CreaGen (United States)0.0000031% in 20192010

    Fractional works of CreaGen (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Woburn

    All research institutions in Woburn

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about CreaGen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.